Author: Ken Dropiewski

Head-to-Head Study Validates Consistent Performance of Microcatheter FFR

PARIS & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–ACIST Medical Systems Inc., a Bracco Group Company, today announced results from the ACIST-FFR Study (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) demonstrating the consistent and correlative performance of the Navvus® MicroCatheter compared to standard pressure wire systems. ACIST-FFR is […]

Teleflex to Introduce the New Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump and the Product Portfolio from the Recently Acquired Vascular Solutions, Inc. at the European Association for Percutaneous Cardiovascular Interventions Course (EuroPCR)

WAYNE, Pa.–(BUSINESS WIRE)–May 15, 2017– Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, will showcase its complex PCI product portfolio recently acquired from the purchase of Vascular Solutions and the new Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) at the EuroPCR […]

New Study Confirms Extended Continuous Cardiac Monitoring is More Efficient than Holter Monitoring for Cryptogenic Stroke Patients

SAN FRANCISCO, May 18, 2017 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced study results presented during the European Stroke Organisation Conference in Prague. Findings reveal that Zio® by iRhythm extended continuous ambulatory monitoring is more […]

C.R. Bard, Becton Dickinson Lead Australia Vascular Access Market due to New Technological Advancements

VANCOUVER, British Columbia, May 16, 2017 /PRNewswire/ — According to a new series of reports on the Australia vascular access device market by iData Research (www.idataresearch.com), peripheral intravenous catheters (PIVCs) and dialysis catheters represent the fastest growing segments in the vascular access market in the region. The PIVC segment is growing […]

Edwards Lifesciences (EW)’ Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes

PARIS, May 17, 2017 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced late-breaking data at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter aortic valve replacement (TAVR) patients treated with the Edwards CENTERA valve. These new […]

Acist Medical Systems, Inc. Release: Head-to-Head Study Validates Consistent Performance Of Microcatheter FFR

PARIS & EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–ACIST Medical Systems Inc., a Bracco Group Company, today announced results from the ACIST-FFR Study (Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve measurement) demonstrating the consistent and correlative performance of the Navvus® MicroCatheter compared to standard pressure wire systems. ACIST-FFR is […]

Elixir Medical Announces Outstanding 5-Year Clinical Data For CE Mark-Approved Desolve Novolimus Eluting Bioresorbable Coronary Scaffold System

MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, today announced excellent 5-year clinical data from the DESolve Nx international pivotal clinical trial for the CE Mark-approved, fully bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System. Stefan Verheye, MD, PhD, ZNA Middleheim Hospital, […]

What is the Significance of Lipid-rich Plaque and Should it Influence Targets for PCI?

By Ken Dropiewski Lipid-rich plaque in non-culprit lesions has long been associated with subsequent cardiac events. Unlike culprit lesions, known to be the cause of AMI, non-culprit lesions including those with a core of lipid-rich plaque are often left untreated during an intervention. The fact that these lesions may lead […]

W. L. Gore & Associates Announces Positive Results From REDUCE Clinical Study For PFO Closure

FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) announces positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech […]